Detalles de la búsqueda
1.
OpenSAFELY: The impact of COVID-19 on azathioprine, leflunomide and methotrexate monitoring, and factors associated with change in monitoring rate.
Br J Clin Pharmacol
; 2024 Apr 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-38589944
2.
The impact of COVID-19 on medication reviews in English primary care. An OpenSAFELY-TPP analysis of 20 million adult electronic health records.
Br J Clin Pharmacol
; 2024 Mar 26.
Artículo
en Inglés
| MEDLINE | ID: mdl-38531661
3.
Keeping warfarin patients safe during the COVID-19 pandemic: review of an INR self-testing programme.
Br J Nurs
; 31(3): 142-146, 2022 Feb 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-35152746
4.
Venous thromboembolism and women's health.
Br J Haematol
; 183(3): 346-363, 2018 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-30334572
5.
Rivaroxaban for the treatment of superficial vein thrombosis, experience at King's College Hospital.
Br J Haematol
; 196(1): e3-e6, 2022 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-34355385
6.
Safety of direct-acting oral anticoagulant (DOAC) prescribing: OpenSAFELY-TPP analysis of 20.5 million adults' electronic health records.
BJGP Open
; 2024 Feb 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-38302156
7.
Use of direct oral anticoagulants for venous thromboembolism treatment at extremes of body weight, renal and liver function: an illustrated review.
Res Pract Thromb Haemost
; 7(8): 102240, 2023 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-38193047
8.
Comparative effectiveness of nirmatrelvir/ritonavir versus sotrovimab and molnupiravir for preventing severe COVID-19 outcomes in non-hospitalised high-risk patients during Omicron waves: observational cohort study using the OpenSAFELY platform.
Lancet Reg Health Eur
; 34: 100741, 2023 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-37927438
9.
Eleven key measures for monitoring general practice clinical activity during COVID-19: A retrospective cohort study using 48 million adults' primary care records in England through OpenSAFELY.
Elife
; 122023 07 27.
Artículo
en Inglés
| MEDLINE | ID: mdl-37498081
10.
Pooled Analysis of Rivaroxaban therapy for acute venous thromboembolism in FIRST registry, SWIVTER and DRESDEN NOAC registry.
Res Pract Thromb Haemost
; 6(7): e12829, 2022 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-36324830
11.
Rivaroxaban in acute venous thromboembolism: UK prescribing experience.
Res Pract Thromb Haemost
; 5(7): e12607, 2021 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-34723054
12.
Adherence to rivaroxaban for the treatment of venous thromboembolism-Results from the FIRST registry.
Res Pract Thromb Haemost
; 5(8): e12614, 2021 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-34849447
13.
Fixed dose rivaroxaban can be used in extremes of bodyweight: A population pharmacokinetic analysis.
J Thromb Haemost
; 18(9): 2296-2307, 2020 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-32511863
14.
Factor Xa Inhibitor Plasma Concentrations and Clinical Outcomes in Patients Weighing ≤50 kg-Experience from Four UK Centers.
Thromb Haemost
; 124(2): 177-180, 2024 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-37846464
15.
Performance of age-adjusted and fixed threshold D-dimer to exclude DVT in those with low pre-test probability - Single centre experience.
Thromb Res
; 232: 1-5, 2023 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-37866167
16.
Potentially inappropriate prescribing of DOACs to people with mechanical heart valves: A federated analysis of 57.9 million patients' primary care records in situ using OpenSAFELY.
Thromb Res
; 211: 150-153, 2022 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-35168181
17.
Fixed dose rivaroxaban can be used in extremes of bodyweight: A population pharmacokinetic analysis - Reply to Jacobs & Ryan comment.
J Thromb Haemost
; 19(3): 872-873, 2021 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-33650251
Resultados
1 -
17
de 17
1
Próxima >
>>